4//SEC Filing
Currie Mark G 4
Accession 0001209191-22-035443
CIK 0001446847other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:04 PM ET
Size
9.2 KB
Accession
0001209191-22-035443
Insider Transaction Report
Form 4
Currie Mark G
Chief Scientific Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-06-07$11.65/sh+190,383$2,217,962→ 782,141 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-06-07−190,383→ 0 totalExercise: $11.65Exp: 2023-02-01→ Class A Common Stock (190,383 underlying) - Sale
Class A Common Stock
2022-06-07$12.01/sh−190,383$2,286,500→ 591,758 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The option, vested as to 1.25% on each monthly anniversary of the vesting commencement date for the first 36 months, and as to 4.5833% of the award on each monthly anniversary thereafter, is presently exercisable in full.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001478244
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:04 PM ET
- Size
- 9.2 KB